In Episode 3 of Peptides Explained, we take a closer look at two of the most talked-about peptides in injury recovery circles: BPC-157 and TB-500.

These compounds are often combined in what’s popularly called the “Wolverine Stack,” a nickname that reflects claims of accelerated healing and recovery. But what are these peptides actually doing in the body, and what does the science really say?

In this episode, we break down the biology behind both compounds, how they interact with tissue repair pathways, and why they’ve become so popular in athletic and performance communities.

We discuss:

• What BPC-157 is and how it may influence angiogenesis, tendon repair, and tissue healing
• What TB-500 (a fragment related to thymosin beta-4) does in terms of cell migration and tissue remodeling
• The biological rationale behind combining the two peptides
• What the available animal research suggests — and where human clinical data is still lacking
• Why these peptides remain in a regulatory gray area
• The difference between experimental compounds and FDA-approved peptide therapeutics

The goal of Peptides Explained is clarity, not hype. In each episode we examine the mechanisms, the available data, and the real limitations of what we know today.

Disclaimer:
This podcast is for informational purposes only and does not constitute medical advice. Peptides discussed may have different regulatory statuses and should only be used under the guidance of licensed healthcare professionals.

If you’re interested in the science behind peptides, injury recovery, metabolism, and emerging therapeutic pathways, this episode will give you a clear, evidence-based overview of one of the most talked-about peptide combinations today.